T2EVOLVE

Accelerating development and improving access to CAR and TCR-engineered T cell therapy...

Description

The aim of T2EVOLVE is to develop an innovation ecosystem that will accelerate the development of engineered T cell therapies in the EU....

General Design

Type
Network
Network type
IMI - Research and Innovation
Start/End data collection
2021 until 2025

Networks

Part of networks...